Catalog No.
DVV02826
Expression system
Mammalian cells
Species reactivity
Human respiratory syncytial virus A (strain A2)
Host species
Human
Isotype
IgG1
Applications
Research Grade Biosimilar
Target
F, Fusion glycoprotein F0, Prefusion, Pre-F
Concentration
4.76 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P03420
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names
RSM-01, RSM01, RSM 01
Clone ID
RSM01
Note
For research use only. Not suitable for clinical or therapeutic use.
Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention., PMID:22323598
Cross-neutralization of four paramyxoviruses by a human monoclonal antibody., PMID:23955151
Polyclonal and monoclonal antibodies specific for the six-helix bundle of the human respiratory syncytial virus fusion glycoprotein as probes of the protein post-fusion conformation., PMID:25010277
Influence of Respiratory Syncytial Virus F Glycoprotein Conformation on Induction of Protective Immune Responses., PMID:27009962
Characterization of Pre-F-GCN4t, a Modified Human Respiratory Syncytial Virus Fusion Protein Stabilized in a Noncleaved Prefusion Conformation., PMID:28404847
Pre-fusion RSV F strongly boosts pre-fusion specific neutralizing responses in cattle pre-exposed to bovine RSV., PMID:29057917
Structure and immunogenicity of pre-fusion-stabilized human metapneumovirus F glycoprotein., PMID:29142300
The Complexity of Antibody Responses Elicited against the Respiratory Syncytial Virus Glycoproteins in Hospitalized Children Younger than 2 Years., PMID:29213258
Human respiratory syncytial virus F protein expressed in Pichia pastoris or Escherichia coli induces protective immunity without inducing enhanced respiratory disease in mice., PMID:32144542
Intranasal vaccination with a recombinant protein CTA1-DD-RBF protects mice against hRSV infection., PMID:34545126
HRSV prefusion-F protein with Adju-Phos adjuvant induces long-lasting Th2-biased immunity in mice., PMID:35100303
Longitudinal study of the immune response and memory following natural bovine respiratory syncytial virus infections in cattle of different age., PMID:36112582
Intranasal immunization with HRSV prefusion F protein and CpG adjuvant elicits robust protective effects in mice., PMID:36253219
Antibodies face the challenge against human respiratory syncytial virus., PMID:36634618
Robust and Long-Lasting Immunity and Protection in Mice Induced by Lipopolyplex-Delivered mRNA Vaccines Expressing the Prefusion Protein of Respiratory Syncytial Virus., PMID:39852872
Immunogenicity evaluation of respiratory syncytial virus prefusogenic-F based virus-like-particles consisting of G and M proteins in mice., PMID:40334534
For research use only. Not for human or drug use.
